Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

Published Apr 2, 2020

Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

An impurity in the ingredient ranitidine has been found to increase cancer-risk over time. Find out what over-the-counter heartburn remedies you can safely take instead:

NOW
PLAYING
HER2-Positive Metastatic Breast Cancer Treatment Options
NOW
PLAYING
Ovarian Cancer Recent PARP Inhibitor Approvals
NOW
PLAYING
Some Cancer Patients Can Get Chemotherapy Without A Higher Risk Of COVID-19 Infection, Study Shows
NOW
PLAYING
Coping With PARP Inhibitor Side Effects
NOW
PLAYING
Ovarian Cancer Chemotherapy Side Effects
NOW
PLAYING
Who Should Be Taking PARP Inhibitors for Ovarian Cancer?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.